Contact DMCA Privacy

Robuta

Sponsor of the Day: Jerkmate
https://thenextweb.com/news/storm-therapeutics-56m-series-c Cambridge biotech STORM Therapeutics raises $56M Apr 16, 2026 - STORM Therapeutics raises $56M Series C and doses first patient in Phase 2 sarcoma trial of STC-15, the world’s first RNA enzyme drug to reach human trials. storm therapeuticscambridgebiotechraises56m https://www.stormtherapeutics.com/ Home | Harnessing the power of RNA epigenetics | Cambridge, UK | STORM Therapeutics cambridge ukstorm therapeuticsharnessingpowerrna https://www.stormtherapeutics.com/about/ About us | Harnessing the power of RNA epigenetics | Cambridge, UK | STORM Therapeutics cambridge ukstorm therapeuticsusharnessingpower